Skip to content
Screener

Medpace Holdings, Inc. MEDP Shares (Diluted)

Shares (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
371M-1.9%
IQVIA logo
IQVIAIQV
167.3M-3.4%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
105.5M+48.5%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
37.6M—
NeoGenomics logo
NeoGenomicsNEO
130.8M+2.3%
Simulations Plus logo
Simulations PlusSLP
20.2M+0.6%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.41B+35.7%
Enterprise value$16.05B+31.6%
P/E33.4×+4.5×
P/S5.9×+0.5×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
(Amounts in thousands, except per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Income tax provision30,30134,27854,02237,853
Net income$121,362$90,260$245,232$204,855
Net income per share attributable to common shareholders:
Basic$4.31$3.16$8.66$6.95
Diluted$4.25$3.10$8.53$6.79
Weighted average common shares outstanding:
Basic28,17428,60128,30829,489
Diluted28,55429,14328,76130,165

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s shares (diluted)?
Medpace Holdings, Inc. (MEDP) reported shares (diluted) of 28.6M in Q2 2026.
How has Medpace Holdings, Inc.'s shares (diluted) changed year-over-year?
Medpace Holdings, Inc.'s shares (diluted) decreased by 2.0% year-over-year, from 29.1M to 28.6M.
What is the long-term trend for Medpace Holdings, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s shares (diluted) has grown at a -5.8% compound annual growth rate (CAGR), from 150.7M to 118.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Medpace Holdings, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude